Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lineage Therap ( (LCTX) ) has shared an update.
Lineage Cell Therapeutics has announced a registered direct offering to raise up to $66 million, involving healthcare-focused institutional investors and Broadwood Partners. The deal includes the sale of over 39 million common shares and warrants, with a potential additional $36 million from warrant exercises. The proceeds aim to support working capital and R&D. H.C. Wainwright & Co. is the exclusive placement agent for the offering, anticipated to close pending customary conditions and shareholder approval.
For an in-depth examination of LCTX stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
